Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Jarrard

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Cancer Research|June 26, 1999
p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cellsD F Jarrard, S Sarkar, Y Shi, et al.
Genes, Chromosomes & Cancer|June 1, 1997
Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancerD F Jarrard, G S Bova, C M Ewing, et al.
Cancer Research|November 15, 1995
E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomasJ R Graff, J G Herman, R G Lapidus, et al.
Cancer Research|August 5, 2000
Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancersS Sarkar, K P Jülicher, M S Burger, et al.
Genes & Development|March 7, 1998
Overcoming cellular senescence in human cancer pathogenesisT R Yeager, S DeVries, D F Jarrard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 25, 2025
Ten-year survival rates by PSA nadir in patients with metastatic hormone-sensitive prostate cancer: long-term survival analysis from the ECOG-ACRIN 3805 (CHAARTED) trialA Tripathi, Y Chen, D F Jarrard, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Cancer Research|June 26, 1999
p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cellsD F Jarrard, S Sarkar, Y Shi, et al.
Genes, Chromosomes & Cancer|June 1, 1997
Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancerD F Jarrard, G S Bova, C M Ewing, et al.
Cancer Research|November 15, 1995
E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomasJ R Graff, J G Herman, R G Lapidus, et al.
Cancer Research|August 5, 2000
Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancersS Sarkar, K P Jülicher, M S Burger, et al.
Genes & Development|March 7, 1998
Overcoming cellular senescence in human cancer pathogenesisT R Yeager, S DeVries, D F Jarrard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 25, 2025
Ten-year survival rates by PSA nadir in patients with metastatic hormone-sensitive prostate cancer: long-term survival analysis from the ECOG-ACRIN 3805 (CHAARTED) trialA Tripathi, Y Chen, D F Jarrard, et al.
Pageof 3